|
PER3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.303600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.045000E-01 |
| Normal-vs-Stage2 |
7.786000E-01 |
| Normal-vs-Stage3 |
6.699800E-02 |
| Normal-vs-Stage4 |
3.541900E-03 |
| Stage1-vs-Stage2 |
4.158400E-01 |
| Stage1-vs-Stage3 |
4.05749999999871E-05 |
| Stage1-vs-Stage4 |
1.70830000034705E-07 |
| Stage2-vs-Stage3 |
7.486100E-02 |
| Stage2-vs-Stage4 |
6.260900E-03 |
| Stage3-vs-Stage4 |
1.273800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.586800E-01 |
| Normal-vs-AfricanAmerican |
7.793800E-01 |
| Normal-vs-Asian |
2.011800E-01 |
| Caucasian-vs-AfricanAmerican |
4.637800E-01 |
| Caucasian-vs-Asian |
1.745450E-01 |
| AfricanAmerican-vs-Asian |
2.239800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.112600E-01 |
| Normal-vs-Female |
9.385600E-01 |
| Male-vs-Female |
5.234000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.811200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.608400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.951200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.026400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.694800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.337400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.980200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.696610E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.825160E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.718400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.387700E-04 |
| Normal-vs-Grade 2 |
1.389610E-01 |
| Normal-vs-Grade 3 |
4.169200E-01 |
| Normal-vs-Grade 4 |
1.04860000016416E-07 |
| Grade 1-vs-Grade 2 |
1.054460E-02 |
| Grade 1-vs-Grade 3 |
3.91160000000612E-05 |
| Grade 1-vs-Grade 4 |
1.354250E-04 |
| Grade 2-vs-Grade 3 |
1.119000E-03 |
| Grade 2-vs-Grade 4 |
1.11022302462516E-16 |
| Grade 3-vs-Grade 4 |
9.89669457496234E-11 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.256500E-03 |
| Normal-vs-ccB subtype |
2.138400E-03 |
| ccA subtype-vs-ccB subtype |
2.99760216648792E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.202000E-01 |
| Normal-vs-N1 |
4.357500E-02 |
| N0-vs-N1 |
7.096200E-02 |
|
|
